ZHONGZE THERAPEUTICS
ZHONGZE Therapeutics is a clinical stage biotech company focused on the discovery, development and commercialization of innovative and transformative therapies for both psychiatric and neurological disorders.
ZHONGZE THERAPEUTICS
Industry:
Biotechnology
Founded:
2021-07-23
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.zhongzetherapeutics.com
Status:
Active
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF SSL By Default Mobile Non Scaleable Content Microsoft Azure DNS PHP PHP 7 DigiCert SSL Encryption Everywhere
Similar Organizations
Aurum Healthcare
Aurum Healthcare is a clinical-stage biotechnology company.
Tychan
Tychan is a clinical-stage biotechnology company.
Investors List
CQY Capital
CQY Capital investment in Seed Round - Zhongze Therapeutics
Cenova
Cenova investment in Seed Round - Zhongze Therapeutics
Official Site Inspections
http://www.zhongzetherapeutics.com
- Host name: 47.116.20.86
- IP address: 47.116.20.86
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Zhongze Therapeutics"
上海中泽医药
中泽医药是一家面向世界的创新药自主研发公司， 公司围绕精神分裂症未满足的临床需求，进行多靶点、多机制的梯队管线 ...See details»
上海中泽医药 - zhongzetherapeutics.com
2022-04-06 Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of ZZ6398 in Healthy VolunteersSee details»
About Zhongze
ZHONGZE Therapeutics is a clinical-stage biotech company focusing on the research, development and commercialization of innovative agents for schizophrenia.Our most …See details»
Zhongze Therapeutics - Crunchbase Company Profile …
ZHONGZE Therapeutics is a clinical stage biotech company focused on the discovery, development and commercialization of innovative and …See details»
Shanghai Zhongze Pharmaceutical Technology Co., Ltd
Explore Shanghai Zhongze Pharmaceutical Technology Co., Ltd with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, Disease Domain:Nervous ...See details»
Zhongze Therapeutics Company Profile 2024: …
Zhongze Therapeutics General Information Description. Developer of innovative drugs designed for CNS diseases. The company focuses on the discovery, development and commercialization of innovative and transformative …See details»
Zhongze Therapeutics - VentureRadar
ZHONGZE Therapeutics is a clinical stage biotech company focused on the discovery, development and commercialization of innovative and transformative... ... Find out ...See details»
Zhongze Therapeutics | VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Shanghai Zhongze Pharmaceutical Technology Co., Ltd
了解Shanghai Zhongze Pharmaceutical Technology Co., Ltd (上海中泽医药科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 7篇新闻，疾病领域:神经系统疾病， …See details»
上海中泽医药 - 公司详情 - 融资历史 - innoHere英诺嘿呀
上海中泽医药是一家临床阶段创新药物研发公司，专注于通过自主研发和产品引进相结合的模式开发针对中枢神经系统（CNS）疾病的优质创新药物，致力于开发出可以改变病程进展的CNS …See details»
中泽医药-动脉网 - vbdata.cn
Sep 8, 2017 中泽医药是一个面向世界的临床阶段创新药物研发公司。公司专注于通过自主研发和产品引进相结合的模式开发针对CNS疾病的优质创新药物。我们基于神经可塑性假说，拥有表 …See details»
CONTACT US - zhongzetherapeutics.com
ZHONGZE THERAPEUTICS Address: Room 1101, 781 Cailun Road, Pudong New District, Shanghai, China Phone: +86 (21) 58787077 E-mail: [email protected] …See details»
Zhongze Therapeutics Announces Successful Completion Of The …
SHANGHAI, April 1, 2022 /PRNewswire/ -- Zhongze Therapeutics, a clinical stage biotech company focused on the discovery, development and commercialization of innovative and …See details»
上海中泽医药 | 项目信息-36氪
上海中泽医药是一家临床阶段创新药物研发公司，专注于通过自主研发和产品引进相结合的模式开发针对中枢神经系统（CNS）疾病的优质创新药物，致力于开发出可以改变病程进展的CNS …See details»
NEWS - zhongzetherapeutics.com
Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of ZZ6398 in Healthy Volunteers. SHANGHAI, CHINA, April. 1, 2022– …See details»
Zhongze Announces Collaboration with Fudan Prof. Nashat …
Mar 8, 2022 [email protected]. You just read: Zhongze Announces Collaboration with Fudan Prof. Nashat Abumaria to Develop Novel AD Therapies. News Provided By. …See details»
ZHONGZE Completed Series Pre-A Round Financing of 10 million …
Recently, ZHONGZE Therapeutics has completed a Series Pre-A round financing of 10 million dollars. The fund will be used for the development of ZHONGZE's innovative CNS product …See details»